Unbranded disease awareness
Campaigns that help people recognise symptoms and seek medical advice, without naming or pointing to a product.
SupportsPublic health and category growth.
30-minute call. Live account teardown. 3–5 fixes to run this week — even if you never hire us.
We'll be in touch within 4 hours. Check your email — a confirmation is on its way.
Build a credible pharma brand online, from disease awareness and healthcare professional engagement to OTC campaigns and employer branding, with medical and legal review built into every post.
For pharmaceutical manufacturers, OTC and consumer health brands, nutraceutical companies, API and CDMO businesses and distributors across India. For hospitals and clinics, see healthcare social media marketing.
Pharma can’t market like a consumer brand. Prescription medicines cannot be promoted to the public in India, and promotion to healthcare professionals is governed by the Uniform Code for Pharmaceutical Marketing Practices, 2024.
That doesn’t mean pharma has to stay off social media. Companies can run unbranded disease awareness, share corporate and research news, build an employer brand, engage healthcare professionals with scientific content through appropriate channels, and market OTC, nutraceutical and wellness products within advertising standards.
The difference is process. Every post needs medical and legal review, comments must be monitored for adverse event mentions, and different audiences need separate accounts or clear boundaries.
Our workflow is built around your review process, not the other way round.
Brief→Draft→Medical review→Legal & regulatory→Publish & monitor
Audit trailEvery post keeps its approval record, so you can show who signed off what and when.
Our social media marketing for pharma companies is organised by audience, with a separate content plan and approval route for each.
Campaigns that help people recognise symptoms and seek medical advice, without naming or pointing to a product.
SupportsPublic health and category growth.
Scientific updates, CME and conference announcements and medical affairs content for healthcare professionals.
SupportsCredibility with prescribers.
Consumer campaigns for products that can be advertised, within ASCI’s healthcare guidelines.
SupportsBrand demand where it is permitted.
Company news, manufacturing quality, CSR and hiring content for LinkedIn and Instagram.
SupportsTalent and investor confidence.
Monitoring comments and mentions, and routing possible adverse events to your pharmacovigilance team.
SupportsCompliance and early warning.
Moderation and replies using pre-approved responses, with escalation for medical questions.
SupportsSafe, consistent conversations.
LinkedIn content and campaigns aimed at procurement and R&D teams at other pharma companies.
SupportsExport and partnership enquiries.
Monthly reporting by audience: reach, engagement, enquiries and approval turnaround.
SupportsKnowing what works. See attribution & analytics.
The plan depends on what you make and who you sell to.
Branded generics and specialty products. Priority: corporate brand, HCP engagement and disease awareness.
Products that can be advertised. Priority: consumer campaigns within ASCI guidelines.
Supplements and wellness ranges. Priority: education-led content without disease claims.
Selling to other pharma companies. Priority: LinkedIn, capability content and trade-show campaigns. See our manufacturing marketing approach.
Trade relationships. Priority: availability, partnerships and recruitment.
We plan channels and content by audience, with clear boundaries between them.
| Audience | Main channels | What we create |
|---|---|---|
| Doctors & HCPs | LinkedIn, medical affairs channels | Scientific updates, CME and conference news |
| Patients & public | Instagram, Facebook, YouTube | Unbranded disease awareness and healthy living |
| OTC & wellness buyers | Instagram, YouTube, Meta ads | Product campaigns where advertising is permitted |
| Pharmacists & trade | LinkedIn, WhatsApp communities | Availability, partnerships and trade news |
| Talent & investors | Culture, quality, hiring and company milestones |
Nothing goes live without your medical and legal sign-off, and any comment mentioning a side effect reaches your pharmacovigilance team.
We work within the Uniform Code for Pharmaceutical Marketing Practices 2024, the Drugs and Magic Remedies Act, the Drugs and Cosmetics rules on advertising and ASCI’s healthcare guidelines. We are a marketing agency, not a regulatory consultancy, so your regulatory team remains the final authority on every claim.
Portfolio, audiences, markets and existing approvals.
Current accounts, content and risks.
Account structure, approval routes and escalation rules.
Quarterly calendar by audience.
Medical, legal and regulatory review of each batch.
Scheduling and moderation with approved responses.
Monitoring and adverse event routing.
Monthly reporting by audience.
Success looks different for each audience, so we report on each separately.
Good social media marketing for pharma is measured by credibility with professionals, awareness with the public and enquiries from partners, not by follower counts alone.
Pharma companies use social media for unbranded disease awareness, corporate and employer branding, scientific engagement with healthcare professionals and, for OTC and wellness products, consumer campaigns. Prescription medicines cannot be promoted to the public, so every post needs medical and legal review.
Read the full answer →They can run unbranded awareness, corporate and OTC or wellness campaigns, subject to Meta’s policies and Indian advertising rules. Prescription brands should not be advertised to the public. Ads must avoid disease claims and targeting based on health conditions.
Read the full answer →A comment that mentions a possible side effect may need to be reported to the company’s pharmacovigilance team. Your agency should monitor comments, use pre-approved responses and escalate such mentions within agreed timelines.
Read the full answer →Yes. The Uniform Code for Pharmaceutical Marketing Practices, 2024 governs how companies promote medicines to healthcare professionals, and its principles apply to digital and social channels. Claims must be accurate, balanced and capable of substantiation, and your regulatory team should review content.
Read the full answer →Yes. LinkedIn suits scientific updates, conference and CME announcements, corporate news, B2B marketing for API and CDMO businesses, and hiring. It reaches doctors, partners, investors and talent without consumer-facing promotion.
Read the full answer →It depends on your medical, legal and regulatory review process. Many teams need one to three weeks per batch. Planning a monthly or quarterly calendar ahead and sending content in batches keeps posting consistent despite long review cycles.
Read the full answer →More answers in our healthcare and pharma marketing FAQs.
Tell us about your portfolio and audiences. We’ll review your current accounts and suggest a compliant plan for social media marketing for pharma that your review teams can work with.
Prefer to talk? WhatsApp +91 96632 72633
Related: Healthcare social media · Medical device marketing · Manufacturing marketing · Healthcare websites · Guide: pharma digital marketing in India
Thanks — we'll review and get back within one working day. Want to talk sooner? WhatsApp us.
Free · 30 min · No pitch
Share a few details and we'll get back within one business day with a shortlist of quick wins for your funnel.
Free website teardown
0 → 1,000+ qualified leads a month for a Chennai real estate developer, after we rebuilt their site and funnel.
Tell us where to send it. We’ll review your site and send you 3 specific fixes to get more enquiries — within 48 hours, free.
We’ll review your site and WhatsApp you the 3 fixes within 48 hours. Want to talk sooner?
Chat on WhatsAppWebsite security powered by MilesWeb